Structure Database (LMSD)

LMSD: Structure-based search results

LM_ID	Common Name	Systematic Name	Formula	Mass	Main Class	Sub Class
LMFA04010001	20-F4-NeuroP	(4Z,7Z,10Z)-12-(3,5-dihydroxy-2-((E)-3- hydroxypent-1-en-1-yl)cyclopentyl) dodeca-4,7,10-trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010123	ent-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010124	ent-13-epi-20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010125	ent-13-epi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010126	ent-20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010127	ent-20-epi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010128	ent-13,20-diepi-20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010129	ent-13,20-diepi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010130	ent-20-epi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010131	20-epi-20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010132	13,20-diepi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1R,2R,3R,5S)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010133	13,20-diepi-20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1S,2S,3R,5S)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010134	20-epi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5- dihydroxy-2-((R,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010135	20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010136	13-epi-20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1R,2R,3R,5S)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010137	13-epi-20-F4c-NeuroP	(4Z,7Z,10Z)-12-((1S,2S,3R,5S)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010138	20-F4t-NeuroP	(4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5- dihydroxy-2-((S,E)-3-hydroxypent-1-en- 1-yl)cyclopentyl)dodeca-4,7,10- trienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]